NEXT: Key Considerations in selecting a polymer prefilled syringe for low-temperature mRNA vaccines

During a pandemic state e.g. COVID-19,the most important goal is to get as many people vaccinated in the shortest time possible. Vaccination centers, with their highly efficient approach, were a paramount step to reach this goal. Multi-dose vials allowed for fast availability of vaccines and trained health care workers prepared the syringes around the clock to support the high vaccination rate.With that in mind, most public health experts currently agree that the COVID-virus 
is here to stay. We are shifting from a pandemic state into an endemic one, which means that we will likely see a periodic re-vaccination such as a yearly booster shot for high-risk patients, similar to the flu shot. This will drive a few changes to the vaccination approach. First, vaccination will likely happen more at a general practitioner or local pharmacy. Most developed countries have a vaccination rate of 50- 80% of the entire population with some countries reaching even a 90% level for adults. The once so important vaccination centers are therefore disappearing because there is simply less need for efficient mass vaccination at a later stage. 

Register for the SCHOTT ID and get access to SCHOTT Pharma exclusive content:

SCHOTT ID is your central key to valuable information and features related to our products and applications. Whether you are an interested party, customer, or partner, you can benefit from simplified access to extended content, practical tools, and digital offerings alongside our range of products.

Transparent.png